Catalyst Biosciences to Present Multi-Dose Subcutaneous Data for CB 2679d in Individuals with Hemophilia B in an Oral Presentation ...
Pharmacokinetics and activity after daily dosing with high potency FIX variant will be reported Conference call and webcast for investment community to be held Feb. 9, 2018 at 8:30 a.m. EST SOUTH SAN FRANCISCO, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- …